Moderna Shares Surge After Upbeat 2025 Revenue Outlook
Moderna's stock jumped over 17% after the company projected 2025 revenue of $1.9 billion at a healthcare conference, with the CEO citing cost reductions and product launches.
Topic
Latest reporting and analysis tagged with Moderna.
Moderna's stock jumped over 17% after the company projected 2025 revenue of $1.9 billion at a healthcare conference, with the CEO citing cost reductions and product launches.